Capsule endoscopy systems market to hit $399.7m by 2020


Thursday, 17 September, 2015

Allied Market Research has claimed that the capsule endoscopy systems market will generate revenue of almost $400 million by 2020, registering a CAGR of 14.8% during 2015–2020. The company states in its new report that capsule endoscopy will gradually replace conventional gastrointestinal monitoring techniques, largely due to its non-invasiveness and convenience.

Capsule endoscopy uses a wireless disposable video capsule, workstations and recorders for the diagnosis of gastrointestinal disorders such as peptic ulcers, Crohn’s disease and obscure gastrointestinal bleeding (OGB). The capsule aids in capturing images, which are transmitted to the recorders and analysed through workstations and software. Wireless disposable capsules held a 95% share in the overall market in 2014.

The study finds that the wireless disposable capsules segment is projected to be the fastest growing segment in the global capsule endoscopy systems component market to 2020, registering a CAGR of ~15.3% during the forecast period. Within target diseases, the colonic diseases segment is projected to register fastest growth during forecast period. The Asia–Pacific region is projected to be the fastest growing capsule endoscopy market, registering a CAGR of 15.5% during 2015–2020.

Market growth will be driven by key factors such as the increasing popularity of varied capsule types, such as small bowel, oesophagus and colon; a growing ageing population; and rising incidences of gastrointestinal disorders. Growth will be particularly strong in North America and Europe — which collectively accounted for around 83% of the capsule endoscopy systems market revenue in 2014 — due to a large patient base, rising healthcare expenditure and quick adoption of innovative technologies.

To view the report ‘World Capsule Endoscopy Systems — Market Opportunity and Forecast, 2014-2020’, visit the Allied Market Research website.

Related News

Shingles vaccine may reduce risk of heart attack and stroke 

Vaccination with either the recombinant herpes zoster vaccine or the live-attenuated zoster...

Perioperative trial offers insights into brain cancer treatment

Victorian brain cancer researchers have used an innovative process to learn how a new drug...

New molecular mechanism found for depression

Depression may not only result from simple neuronal damage but can also arise from the...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd